122 related articles for article (PubMed ID: 38687471)
1. The long-term outcomes and safety of severe aplastic anemia treated with porcine antilymphocyte globulin plus cyclosporine, with or without thrombopoietin receptor agonists: a double-center retrospective study.
Xu S; Xiao Y; Liang X; Lu Y; Deng M
Expert Rev Hematol; 2024; 17(4-5):181-188. PubMed ID: 38687471
[TBL] [Abstract][Full Text] [Related]
2. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
[TBL] [Abstract][Full Text] [Related]
3. Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
Cui Q; Sha P; Chen H; Shen H; Qin L; Li Z; Wu T; Wang Z
Int J Hematol; 2018 Jan; 107(1):64-68. PubMed ID: 28900860
[TBL] [Abstract][Full Text] [Related]
4. [Porcine anti-human lymphocyte globulin plus cyclosporine A therapy for severe aplastic anemia].
Han B; Yan SY; Zou N; Zhang W; Li J; Duan MH; Jiao L; Zhuang JL; Wang SJ; Zhou DB; Zhu TN; Xu Y; Zhao YQ; Shen T
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):241-4. PubMed ID: 21569706
[TBL] [Abstract][Full Text] [Related]
5. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
Chen M; Liu C; Zhuang J; Zou N; Xu Y; Zhang W; Li J; Duan M; Zhu T; Cai H; Cao X; Wang S; Zhou D; Han B
Eur J Haematol; 2016 Mar; 96(3):291-6. PubMed ID: 25996247
[TBL] [Abstract][Full Text] [Related]
7. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
Lan Y; Chang L; Yi M; Cai Y; Feng J; Ren Y; Liu C; Chen X; Wang S; Guo Y; Zhang A; Liu L; Zhang J; Zhu X
Ann Hematol; 2021 Jan; 100(1):53-61. PubMed ID: 33033910
[TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience.
Zhang XT; Wang X; Cao J; Chen W; Qi KM; Qi N; Liang F; Dong XY; Tang GF; Li DP; Sang W; Li ZY; Cheng H; Xu KL
Hematology; 2021 Dec; 26(1):1025-1030. PubMed ID: 34895103
[TBL] [Abstract][Full Text] [Related]
12. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
Peffault de Latour R; Kulasekararaj A; Iacobelli S; Terwel SR; Cook R; Griffin M; Halkes CJM; Recher C; Barraco F; Forcade E; Vallejo JC; Drexler B; Mear JB; Smith AE; Angelucci E; Raymakers RAP; de Groot MR; Daguindau E; Nur E; Barcellini W; Russell NH; Terriou L; Iori AP; La Rocca U; Sureda A; Sánchez-Ortega I; Xicoy B; Jarque I; Cavenagh J; Sicre de Fontbrune F; Marotta S; Munir T; Tjon JML; Tavitian S; Praire A; Clement L; Rabian F; Marano L; Hill A; Palmisani E; Muus P; Cacace F; Frieri C; van Lint MT; Passweg JR; Marsh JCW; Socié G; Mufti GJ; Dufour C; Risitano AM;
N Engl J Med; 2022 Jan; 386(1):11-23. PubMed ID: 34986284
[TBL] [Abstract][Full Text] [Related]
13. [A long-term follow up study on 345 severe aplastic anemia patients treated with antithymocyte globulin/lymphoglobulin].
Shao YQ; Li XX; Ge ML; Shi J; Zhang J; Huang JB; Huang ZD; Nie N; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):30-5. PubMed ID: 23597461
[TBL] [Abstract][Full Text] [Related]
14. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
Bacigalupo A; Broccia G; Corda G; Arcese W; Carotenuto M; Gallamini A; Locatelli F; Mori PG; Saracco P; Todeschini G
Blood; 1995 Mar; 85(5):1348-53. PubMed ID: 7532040
[TBL] [Abstract][Full Text] [Related]
15. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
Bacigalupo A; Bruno B; Saracco P; Di Bona E; Locasciulli A; Locatelli F; Gabbas A; Dufour C; Arcese W; Testi G; Broccia G; Carotenuto M; Coser P; Barbui T; Leoni P; Ferster A
Blood; 2000 Mar; 95(6):1931-4. PubMed ID: 10706857
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of porcine antihuman lymphocyte immunoglobulin compared to rabbit antithymocyte immunoglobulin as a first-line treatment against acquired severe aplastic anemia.
Liu L; Ding L; Hao L; Zhang X; Li X; Zhang L; Hao Z; Lei M; Zhang Y; Wu D
Ann Hematol; 2015 May; 94(5):729-37. PubMed ID: 25604721
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of transfusion-dependent nonsevere aplastic anemia with cyclosporine A plus ATG/ALG versus cyclosporine A plus androgens: a retrospective single center study].
Song L; Peng GX; Wu ZJ; Zhang L; Jing LP; Zhou K; Li Y; Li Y; Ye L; Li JP; Fan HH; Zhao X; Yang WR; Yang Y; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):946-951. PubMed ID: 27995878
[TBL] [Abstract][Full Text] [Related]
18. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
Zhang X; Li Z; Geng W; Song B; Wan C
Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
[TBL] [Abstract][Full Text] [Related]
19. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
